ABOUT US
Mission History Boards of Directors Staff Join PPTA
MEMBER COMPANIES TOPICS
U.S.
Federal State Regulatory
European Union
Patient Access & Health Policy Institutions EU Member States
Other Countries
Organizations and Institutions
International
International Institutions
PLASMA PROTEIN THERAPIES
Plasma-derived Therapies
Plasma & Blood Become a Donor Find a Donation Center FAQ
Recombinant Therapies Diseases and Treatments
PROGRAMS & STANDARDS
Donor Deferral (NDDR) Patient Notification System IQPP QSEAL U.S. Supply Data
PATIENT RESOURCES
Learn About Patients Patient Groups Patient Notification System Resources IVIG Manufacturers
PUBLICATIONS
The Source
This Season's Issue Why Subscribe? Subscription / Order Center Email the Editor Advertising Opportunities
Fact Sheets Brochures
PPTA DHQ NEWSROOM
Calendar of Events Press Releases Industry Facts Videos Press Contacts Subscribe to e-releases
CONTACT  

2012 International Plasma Protein Congress

Supply Data

The Source

PPTA DeutschlandPPTA FrancePPTA Netherlands

Home > Topics > European Union > Patient Access & Health Policy
Print Email

European Union Patient Access and Health Policy

  • PPTA Position Statement: EU's Role in Global Health (December 2009)
  • European Parliament Call for Action - Rare Plasma Related Disorders (June 2009)
  • PPTA Position Statement Regarding European Commission Call for Tender on Testing Laboratories and Testing Methods (October 2008)
  • PPTA Position Statement Regarding European Commission Draft Directive on Cross-border Healthcare (October 2008)
  • PPTA Position Paper: European Commission's Public Consultation on Rare Diseases: Europe's Challenges (February 2008)
  • PPTA Position Paper: European Consultation on the Future of Pharmaceuticals for Human Use (October 2007)
  • PPTA Position Paper: Patient Information (June 2007)
  • PPTA Position Paper: The Place of Chronic, Congenital Diseases Within an EU Framework for Health Services (December 2006)
HOMECONTACTNEWSROOMSITE MAPTERMS OF USEPRIVACY POLICY